NDC11 16571078450
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 16571-0784-50 | 16571-0784 |
| 16571-784-50 | 16571-784 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gemfibrozil | GEMFIBROZIL | Rising Pharma Holdings, Inc. | 8f36abfa-dc52-4c99-8a4a-b0cb80c3249a | 2024-05-15 | Warnings, Adverse reactions | 16571-784-50 16571-784 16571078450 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.